Chemomab Therapeutics : Notice and Proxy Statement with respect to the Company's annual general meeting of the shareholders (the Meeting ) to be held on August 7, 2023, describing the proposals to be voted upon at the meeting, the procedure for voting in person or by proxy at the meeting and various other details related to the meeting

July 3, 2023





Dear Chemomab Therapeutics Ltd. Shareholders:





We cordially...

Related Keywords

Brussels ,Bruxelles Capitale ,Belgium ,Herzliya ,Tel Aviv ,Israel ,Jerusalem ,Israel General ,Ramat Gan ,United States ,Castries ,Saint Lucia ,Delaware ,London ,City Of ,United Kingdom ,American ,Israeli ,Nissim Darvish ,Claude Nicaise ,Balan Moses ,Sigal Fattal ,Jill Quigley ,Wadi Mor ,Peter Thiel ,Matthew Frankel ,Neil Cohen ,Fabian Hansen ,Kiryat Atidim ,Bristol Myers Squibb ,Somekh Chaikin ,Orbimed Biofund ,Kobi George ,Christian Angermayer ,Broadcom ,Centillion Fund ,Hetz Ventures Management Ltd ,Meeting Of Chemomab Therapeutics Ltd ,Nm Rothschild Sons ,Ebay ,Apeiron Investment Group Ltd ,Anchiano Therapeutics Ltd ,Apeiron Group ,Alexion Pharmaceuticals Inc ,Nasdaq ,Chemomab Therapeutics Ltd ,Israeli Companies Law ,Dear Chemomab Therapeutics Ltd ,Compensation Committee ,Board Of Directors The Company ,Brussels University ,Company American Depositary Shares Adss ,Company Or Chemomab ,Committee Members ,Articles Of Association ,Broadridge Financial Solutions ,Orbimed Israel Gp Ltd ,Castel Partners Ltd ,Board Of Chemomab Therapeutics Ltd ,Governance Nominating Committee ,Public Accounting Firm ,Orbimed Israel Partners Limited Partnership ,Oxford University ,Presight Capital Fund ,Chemomab Ltd ,Exchange Commission ,Compensation Committee Of Sarepta Therapeutics Inc ,Audit Committee Pre ,Clinical Regulatory Services ,Apeiron Presight Capital Fund ,Audit Services Of Independent Auditors ,Audit Committee ,Companies Law ,Centillion Fund Inc ,Chemomab Therapeutics ,Annual General Meeting ,Law Offices ,Hillel Road ,American Depositary Shares ,New York Mellon ,Annual Meeting ,Chief Executive Officer ,General Meeting ,Chief Financial Officer ,Deposity Agreement ,Votes Cast ,Voting Instruction Card ,Receive More ,One Proxy ,Matters Listed ,Return My Proxy Card ,Annual General ,Current Report ,Investor Relations ,Greater Shareholders ,Med Israel ,Executive Officers ,Orbimed Israel Biofund ,Orbimed Israel ,Rivendell Investments ,Capital Fund One ,Annual Report ,Board Leadership Structure ,Risk Oversight ,Corporate Secretary ,Chief Scientific ,Exchange Act ,Business Conduct ,Under Nasdaq ,Nominating Committee ,Gender Identity ,Demographic Background ,Native American ,Pacific Islander ,North African ,More Races ,Sarepta Therapeutics ,Mynoryx Therapeutics ,Senior Vice President ,Alexion Pharmaceuticals ,Internal Medicine ,Clinical Oncology ,Anchiano Therapeutics ,Castel Partners ,Israel Seed Partners ,Business Editor ,Jerusalem Post ,Sons Limited ,Oriental Studies ,Chief Scientific Officer ,Compensation Policy ,Based Incentive Plan ,Mor Compensation Changes ,Director Compensation Package ,Director Compensation ,Chair Committee ,Independent Registered Public Accounting Firm ,Audit Committee Pre Approval ,Permissible Non Audit Services ,Independent Auditors ,